ExonHit, RedPath Terminate Acquisition Deal
October 25, 2010
ExonHit, RedPath Terminate Acquisition Deal
The deal was abandoned after the two companies could not reach new terms and conditions following a Medicare contractor's decision to cover only one of RedPath's tests.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.